Bio

Tom is a Director and joined the team in 2023. Tom has over 15 years of professional experience across a variety of clinical and operational roles. Prior to joining iCON, Tom was Director of Corporate Strategy at MiroBio. Tom is primarily focused on overseeing investments across iCON’s funds. Tom holds a Master’s degree in Bioscience Enterprise (Cambridge University), as well as a Medical Degree & Bachelor’s in Medical Science (Nottingham University). Tom is also a Fellow of the Royal College of Radiologists and a Member of the Royal College of Surgeons of England.